Dgs Capital Management, LLC Pfizer Inc Transaction History

Dgs Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 16, 2023	SELL	$39.39 - $51.28 $25,603 - $33,332	-650 Reduced 9.69%	6,055 $247,000
Q4 2022 Feb 21, 2023	BUY	$41.75 - $54.5 $14,236 - $18,584	341 Added 5.36%	6,705 $343,000
Q3 2022 Feb 21, 2023	SELL	$43.76 - $53.42 $27,393 - $33,440	-626 Reduced 8.96%	6,364 $278,000
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $17,541 - $20,799	-377 Reduced 5.12%	6,990 $366,000
Q1 2022 May 05, 2022	BUY	$45.75 - $56.69 $92,460 - $114,570	2,021 Added 37.8%	7,367 $381,000
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $220,896 - $327,442	5,346 New	5,346 $316,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Dgs Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Dgs Capital Management, LLC with notifications on news.